Navigation Links
Mesa Labs to Participate in the Health-Care Trade Policy Mission in Beijing on April 23-25, 2008
Date:4/18/2008

LAKEWOOD, Colo., April 18 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc., (Nasdaq: MLAB) announced today that John J. Sullivan, President and COO, will participate in a Health-Care Trade Policy Mission led by the U.S. Under Secretary of Commerce. Mesa Labs was selected as one of 15 companies to accompany Under Secretary Christopher A. Padilla on the 3-day event in Beijing. The purpose of the mission is to provide a forum to better understand the direction of China's new health care reforms, and to maximize opportunities for U.S. suppliers of Medical Devices, Services, and Pharmaceuticals.

Mesa Laboratories, Inc. is a public Colorado corporation that develops, manufactures, and markets instruments and disposable products utilized in connection with industrial applications and health care. For industrial applications, which include pharmaceutical, food, and medical devices, the Company presently markets the DATATRACE(R) data logging systems and RAVEN Biological Indicators. For healthcare applications, the Company markets Dialysate Meters, which are used for quality control in kidney dialysis clinics and RAVEN Biological Indicators, which are used by hospitals and dental offices to assure sterility. The Company is continually performing research and development to expand the application of its technology. For more information visit the Company's web site at http://www.mesalabs.com.


'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
2. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
3. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
4. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
5. Cincinnati Adoption Agency Invited to Participate in Values Voter Presidential Debate
6. Dental Researchers Participate in Global Awareness Initiative
7. @ease Spa is Proud to Participate in Spa Week
8. Synova Healthcare to Participate in Womens Health Care in the New Millennium Conference, as Retail Distribution for the Fem-V(R) Test Kit Expands
9. Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2007 Results Conference Call and Web Cast
10. AMERIGROUP to Participate in National Disability Mentoring Day
11. Crittenton Hospital Medical Center to Participate in United Physicians myWorkspace(R) Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology: